MedTrace Logo

Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis

NCT02242630 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2016-12-14

Study results available
· View outcomes & findings →

Summary

It is currently unknown whether or not the improvement in pain and function related to a "steroid shot" for shoulder pain due to subacromial bursitis is important. This study seeks to determine whether 20 mg or 40 mg of either triamcinolone or methylprednisolone significantly affect improvement in shoulder pain 6 weeks after injection.

Conditions

  • Subacromial Bursitis
  • Shoulder Pain

Interventions

DRUG

Methylprednisolone, 20 mg

Compared with intrabursal triamcinolone

DRUG

Methylprednisolone, 40 mg

Compared with intrabursal triamcinolone

DRUG

Triamcinolone, 20 mg

Compared with methylprednisolone

DRUG

Triamcinolone, 40 mg

Compared with methylprednisolone

Sponsors & Collaborators

  • Keesler Air Force Base Medical Center

    lead FED

Principal Investigators

  • Matthew B Carroll, MD · Keesler Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02242630 on ClinicalTrials.gov